Literature DB >> 18056484

Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts.

Simona Moretti1, Antonio Procopio, Raffaella Lazzarini, Maria Rita Rippo, Roberto Testa, Maurizio Marra, Luca Tamagnone, Alfonso Catalano.   

Abstract

Semaphorins and their receptors (plexins) have pleiotropic biologic functions, including regulation of immune responses. However, the role of these molecules inside the immune system and the signal transduction mechanism(s) they use are largely unknown. Here, we show that Semaphorin3A (Sema3A) triggers a proapoptotic program that sensitizes leukemic T cells to Fas (CD95)-mediated apoptosis. We found that Sema3A stimulation provoked Fas translocation into lipid raft microdomains before binding with agonistic antibody or FasL (CD95L). Disruption of lipid rafts reduced sensitivity to Fas-mediated apoptosis in the presence of Sema3A. Furthermore, we show that plexin-A1, together with Sema3A-binding neuropilin-1, was rapidly incorporated into membrane rafts after ligand stimulation, resulting in the transport of actin-linking proteins into Fas-enriched rafts. Cells expressing a dominant-negative mutant of plexin-A1 did not show Fas clustering and apoptosis on Sema3A/Fas costimulation. This work identifies a novel biologic function of semaphorins and presents an unexpected signaling mechanism linking semaphorin to the tumor necrosis factor family receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056484     DOI: 10.1182/blood-2007-06-096529

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

Review 1.  The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function.

Authors:  Brian P O'Connor; Jenny P-Y Ting
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 3.  Semaphorin3A: A potential therapeutic tool in immune-mediated diseases.

Authors:  Zahava Vadasz; Elias Toubi
Journal:  Eur J Rheumatol       Date:  2017-12-07

4.  Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.

Authors:  S K Baniwal; P K Shah; Y Shi; J H Haduong; Y A Declerck; Y Gabet; B Frenkel
Journal:  Osteoporos Int       Date:  2011-09-01       Impact factor: 4.507

5.  MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis.

Authors:  Yeping Zhou; Youri Adolfs; W W M Pim Pijnappel; Stephen J Fuller; Roel C Van der Schors; Ka Wan Li; Peter H Sugden; August B Smit; Alexander Hergovich; R Jeroen Pasterkamp
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

6.  Proteomic analysis of menstrual blood.

Authors:  Heyi Yang; Bo Zhou; Mechthild Prinz; Donald Siegel
Journal:  Mol Cell Proteomics       Date:  2012-07-20       Impact factor: 5.911

7.  Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development.

Authors:  Kimberly J Reidy; Guillermo Villegas; Jason Teichman; Delma Veron; Wa Shen; Juan Jimenez; David Thomas; Alda Tufro
Journal:  Development       Date:  2009-12       Impact factor: 6.868

8.  Inhibition of semaphorin-3a suppresses lipopolysaccharide-induced acute kidney injury.

Authors:  Xiaofang Tian; Hua Gan; Yizhou Zeng; Hongfei Zhao; Rong Tang; Yunfeng Xia
Journal:  J Mol Med (Berl)       Date:  2018-06-16       Impact factor: 4.599

9.  Genome wide screen identifies microsatellite markers associated with acute adverse effects following radiotherapy in cancer patients.

Authors:  Yuichi Michikawa; Tomo Suga; Atsuko Ishikawa; Hideki Hayashi; Akira Oka; Hidetoshi Inoko; Mayumi Iwakawa; Takashi Imai
Journal:  BMC Med Genet       Date:  2010-08-11       Impact factor: 2.103

10.  Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts.

Authors:  Mariana O Baratti; Yuri B Moreira; Fabiola Traina; Fernando F Costa; Sergio Verjovski-Almeida; Sara T Olalla-Saad
Journal:  BMC Med Genomics       Date:  2010-07-15       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.